Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa dose-finding for allogeneic stem cell transplantation in adults with high-risk hematological malignancies
2007-007593-31Phase 2Active
- Sponsor
- Fondazione Ricerca Trapianto di Midollo Osseo
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thiotepa in hematopoietic malignancies and Conditioning Therapy, sponsored by Fondazione Ricerca Trapianto di Midollo Osseo. Primary endpoint: High-grade toxicity. Started Mar 2009; status: active.
02
Drugs
thiotepa
03
Conditions
hematopoietic malignanciesConditioning Therapy
Beyond the preview
Go deeper on 2007-007593-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007593-31.